The miR-21 antagomir increases the expression level of tissue inhibitor of metalloproteinases 3 (TIMP3), thereby improving insulin resistance and disordered lipid metabolism in STZ-induced T2DM rats [44]. This evidence concerns the gene TIMP3 and type 2 diabetes mellitus.